BeyondSpring, Inc. (BYSI)
0.6386
+0.02
(+2.97%)
USD |
NASDAQ |
Sep 09, 15:06
BeyondSpring Enterprise Value : 18.69M for Sept. 8, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 18.69M |
| September 04, 2026 | 18.60M |
| September 03, 2026 | 18.77M |
| September 02, 2026 | 18.31M |
| September 01, 2026 | 17.96M |
| August 31, 2026 | 18.70M |
| August 28, 2026 | 20.54M |
| August 27, 2026 | 19.51M |
| August 26, 2026 | 21.56M |
| August 25, 2026 | 22.80M |
| August 24, 2026 | 22.35M |
| August 21, 2026 | 22.79M |
| August 20, 2026 | 22.79M |
| August 19, 2026 | 22.87M |
| August 18, 2026 | 22.71M |
| August 17, 2026 | 22.44M |
| August 14, 2026 | 27.69M |
| August 13, 2026 | 34.15M |
| August 12, 2026 | 23.69M |
| August 11, 2026 | 25.67M |
| August 10, 2026 | 25.49M |
| August 07, 2026 | 28.96M |
| August 06, 2026 | 28.96M |
| August 05, 2026 | 33.31M |
| August 04, 2026 | 33.89M |
| Date | Value |
|---|---|
| August 03, 2026 | 41.29M |
| July 31, 2026 | 40.47M |
| July 30, 2026 | 39.65M |
| July 29, 2026 | 40.47M |
| July 28, 2026 | 41.91M |
| July 27, 2026 | 41.29M |
| July 24, 2026 | 39.24M |
| July 23, 2026 | 37.59M |
| July 22, 2026 | 39.65M |
| July 21, 2026 | 44.58M |
| July 20, 2026 | 44.17M |
| July 17, 2026 | 46.23M |
| July 16, 2026 | 45.82M |
| July 15, 2026 | 45.41M |
| July 14, 2026 | 47.87M |
| July 13, 2026 | 47.87M |
| July 10, 2026 | 52.40M |
| July 09, 2026 | 54.45M |
| July 08, 2026 | 61.85M |
| July 07, 2026 | 61.44M |
| July 06, 2026 | 66.79M |
| July 02, 2026 | 70.08M |
| July 01, 2026 | 69.25M |
| June 30, 2026 | 65.14M |
| June 29, 2026 | 70.12M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.865B |
| Alnylam Pharmaceuticals, Inc. | 34.46B |
| Anika Therapeutics, Inc. | 268.42M |
| Savara, Inc. | 993.23M |
| Vericel Corp. | 1.932B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.75M |
| Total Expenses (Quarterly) | 0.909M |
| EPS Diluted (Quarterly) | -0.0206 |
| Earnings Yield | -25.67% |
| Normalized Earnings Yield | -25.67 |